Rigel Pharmaceuticals
RIGL
#6835
Rank
HK$5.70 B
Marketcap
HK$308.19
Share price
-0.91%
Change (1 day)
100.41%
Change (1 year)

Market capitalization of Rigel Pharmaceuticals (RIGL)

Market cap: HK$5.70 Billion

As of July 2026 Rigel Pharmaceuticals has a market cap of HK$5.70 Billion. This makes Rigel Pharmaceuticals the world's 6835th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Rigel Pharmaceuticals from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$5.70 B-8.26%
2025HK$6.21 B175.46%
2024HK$2.25 B14.27%
2023HK$1.97 B-2.52%
2022HK$2.02 B-42.68%
2021HK$3.53 B-22.93%
2020HK$4.58 B63.76%
2019HK$2.79 B-7.01%
2018HK$3.01 B-32.2%
2017HK$4.44 B143.2%
2016HK$1.82 B-14.14%
2015HK$2.12 B37.19%
2014HK$1.55 B-19.86%
2013HK$1.93 B-55.94%
2012HK$4.39 B0.56%
2011HK$4.36 B42.53%
2010HK$3.06 B-20.05%
2009HK$3.83 B69.4%
2008HK$2.26 B-63.6%
2007HK$6.21 B167.24%
2006HK$2.32 B44.53%
2005HK$1.60 B-56.89%
2004HK$3.73 B69.07%
2003HK$2.20 B462.38%
2002HK$0.39 B-71.32%
2001HK$1.36 B-52.34%
2000HK$2.87 B

End of Day market cap according to different sources

On Jul 21st, 2026 the market cap of Rigel Pharmaceuticals was reported to be:

HK$5.70 Billion
by Nasdaq info icon info icon
HK$5.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
HK$1.549 T 27,076.98%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$2.058 T 36,008.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
HK$0.24 B-95.78%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
HK$29.31 B 414.10%๐Ÿ‡บ๐Ÿ‡ธ USA